title: Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy.
authors.affiliation: Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada ian.tannock@uhn.ca.
authors.forename: I F
authors.initials: IF
authors.lastname: Tannock
authors.affiliation: Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy.
authors.forename: C N
authors.initials: CN
authors.lastname: Sternberg
mesh_terms: D006801:Humans; D008297:Male; D011467:Prostate / Q000473:pathology*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000628:therapy*